(Q41519401)

2 October 2017

Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women (English)

1 reference

2 October 2017

1 reference

23

1 reference

2 October 2017

12

Akinyemi I Ojesina

0 references

Samuel S Freeman

Samuel S Freeman

15

0 references

Joseph Kwong

Joseph Kwong

17

0 references

Matthew Meyerson

Matthew Meyerson

28

0 references

Gad Getz

25

Gad Getz

1 reference

2 October 2017

Tony K H Chung

1

1 reference

2 October 2017

Paul Van Hummelen

2

1 reference

2 October 2017

Paul K S Chan

3

1 reference

2 October 2017

Tak Hong Cheung

4

1 reference

2 October 2017

So Fan Yim

5

1 reference

2 October 2017

Mei Y Yu

6

1 reference

2 October 2017

Matthew D Ducar

7

1 reference

2 October 2017

Aaron R Thorner

8

1 reference

2 October 2017

Laura E MacConaill

9

1 reference

2 October 2017

Graeme Doran

10

1 reference

2 October 2017

Chandra Sekhar Pedamallu

11

1 reference

2 October 2017

Raymond R Y Wong

13

1 reference

2 October 2017

Vivian W Wang

14

1 reference

2 October 2017

Tat San Lau

16

1 reference

2 October 2017

Loucia K Y Chan

18

1 reference

2 October 2017

Menachem Fromer

19

1 reference

2 October 2017

Taymaa May

20

1 reference

2 October 2017

Michael J Worley

21

1 reference

2 October 2017

Katharine M Esselen

22

1 reference

2 October 2017

Michael Lawrence

24

1 reference

2 October 2017

David I Smith

26

1 reference

2 October 2017

Christopher P Crum

27

1 reference

2 October 2017

Ross S Berkowitz

29

1 reference

2 October 2017

Yick Fu Wong

30

1 reference

2 October 2017

language of work or name

English

0 references

publication date

13 February 2015

1 reference

International Journal of Cancer

2 October 2017

1 reference

2 October 2017

137

1 reference

2 October 2017

776-783

1 reference

2 October 2017

4

1 reference

Cervical cancer trends in the United States: a 35-year population-based analysis

2 October 2017

1 reference

Radical hysterectomy for stage IB adenocarcinoma of the cervix: the University of Miami experience.

21 January 2018

1 reference

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

21 January 2018

1 reference

SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines

21 January 2018

1 reference

Mutations in Hedgehog pathway genes in fetal rhabdomyomas

21 January 2018

1 reference

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma

21 January 2018

1 reference

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

21 January 2018

1 reference

PathSeq: software to identify or discover microbes by deep sequencing of human tissue

21 January 2018

1 reference

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

21 January 2018

1 reference

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

21 January 2018

1 reference

Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA).

21 January 2018

1 reference

A method and server for predicting damaging missense mutations

21 January 2018

1 reference

Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment

21 January 2018

1 reference

Landscape of genomic alterations in cervical carcinomas

21 January 2018

1 reference

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

21 January 2018

1 reference

A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas

21 January 2018

1 reference

Carcinogenesis of PIK3CA.

21 January 2018

1 reference

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix

21 January 2018

1 reference

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

21 January 2018

1 reference

Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells

21 January 2018

1 reference

PIK3CA and KRAS mutations predict for response to everolimus therapy: now that's RAD001

21 January 2018

1 reference

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.

21 January 2018

1 reference

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies

21 January 2018

1 reference

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies

21 January 2018

1 reference

Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29456

1 reference

2 October 2017

1 reference